State Street’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

State Street’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-211,205	Closed	-$13.1M	–	4448
2023 Q4	$13.1M	Buy	+211,205	New	+$5.25M	﹤0.01%	2445

State Street's RYZB Position: Q1 2024 in Review

State Street sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 211,205 shares — an estimated $13.1M sold.

State Street first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $13.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

State Street reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
State Street sold 211,205 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $13.1M.
State Street first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
State Street's RayzeBio, Inc. Common Stock position peaked at $13.1M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on State Street's 13F filing for Q1 2024, filed 15 May 2024.